IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 228 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $209,273 | -28.5% | 45,994 | +10.6% | 0.00% | 0.0% |
| Q2 2023 | $292,716 | +43.9% | 41,579 | +24.9% | 0.00% | 0.0% |
| Q1 2023 | $203,414 | -1.9% | 33,292 | +2.6% | 0.00% | 0.0% |
| Q4 2022 | $207,394 | -27.7% | 32,456 | +8.5% | 0.00% | 0.0% |
| Q3 2022 | $287,000 | -10.9% | 29,909 | +2.5% | 0.00% | 0.0% |
| Q2 2022 | $322,000 | +19.3% | 29,178 | +79.6% | 0.00% | 0.0% |
| Q1 2022 | $270,000 | -36.0% | 16,245 | -26.5% | 0.00% | 0.0% |
| Q4 2021 | $422,000 | -48.3% | 22,096 | -33.3% | 0.00% | -50.0% |
| Q3 2021 | $817,000 | +14.3% | 33,120 | +20.6% | 0.00% | 0.0% |
| Q2 2021 | $715,000 | +11.0% | 27,463 | +35.0% | 0.00% | 0.0% |
| Q1 2021 | $644,000 | -38.7% | 20,338 | -10.2% | 0.00% | -50.0% |
| Q4 2020 | $1,050,000 | +35.1% | 22,637 | -4.1% | 0.00% | 0.0% |
| Q3 2020 | $777,000 | +23.1% | 23,599 | +2.7% | 0.00% | +33.3% |
| Q2 2020 | $631,000 | -13.0% | 22,976 | -5.1% | 0.00% | -40.0% |
| Q1 2020 | $725,000 | -39.3% | 24,208 | -43.9% | 0.01% | -16.7% |
| Q4 2019 | $1,195,000 | +40.9% | 43,173 | -7.3% | 0.01% | +20.0% |
| Q3 2019 | $848,000 | -26.8% | 46,583 | -1.4% | 0.01% | -28.6% |
| Q2 2019 | $1,159,000 | +128.1% | 47,266 | -11.5% | 0.01% | +133.3% |
| Q1 2019 | $508,000 | +8.5% | 53,438 | +1.1% | 0.00% | 0.0% |
| Q4 2018 | $468,000 | -15.2% | 52,874 | +7.8% | 0.00% | -25.0% |
| Q3 2018 | $552,000 | -11.1% | 49,033 | +1.1% | 0.00% | 0.0% |
| Q2 2018 | $621,000 | -26.4% | 48,497 | -2.9% | 0.00% | -20.0% |
| Q1 2018 | $844,000 | +118.7% | 49,940 | +3.5% | 0.01% | +66.7% |
| Q4 2017 | $386,000 | +27.8% | 48,269 | +24.0% | 0.00% | 0.0% |
| Q3 2017 | $302,000 | +11.9% | 38,940 | +6.2% | 0.00% | 0.0% |
| Q2 2017 | $270,000 | – | 36,674 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 11,826,299 | $130,562,000 | 4.09% |
| MPM BioImpact LLC | 1,200,000 | $13,248,000 | 3.68% |
| Finepoint Capital LP | 960,200 | $10,601,000 | 3.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,011 | $273,000,000 | 2.85% |
| Avoro Capital Advisors LLC | 9,220,000 | $101,789,000 | 2.01% |
| Long Focus Capital Management, LLC | 1,625,000 | $17,940,000 | 1.88% |
| 683 Capital Management, LLC | 2,000,000 | $22,080,000 | 1.56% |
| Parametrica Management Ltd | 115,870 | $1,268,000 | 1.38% |
| Boxer Capital, LLC | 1,935,133 | $21,364,000 | 1.35% |
| Soleus Capital Management, L.P. | 719,600 | $7,944,000 | 1.24% |